Precision Biosciences (DTIL) Interest Coverage Ratio Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,150.63% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 53.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.28% |
| Dec 31, 2025 | 156.71% |
| Sep 30, 2025 | 31.30% |
| Jun 30, 2025 | -241.73% |
| Mar 31, 2025 | -756.32% |
| Dec 31, 2024 | -146.46% |
| Sep 30, 2024 | -287.19% |
| Jun 30, 2024 | 862.04% |
| Mar 31, 2024 | 71.49% |
| Dec 31, 2023 | -3.22% |
| Sep 30, 2023 | 40.77% |
| Jun 30, 2023 | 96.59% |
| Mar 31, 2023 | 96.07% |
| Dec 31, 2022 | 95.70% |
| Sep 30, 2022 | 82.73% |
| Jun 30, 2022 | -118.42% |